1. Home
  2. SSD vs SYRE Comparison

SSD vs SYRE Comparison

Compare SSD & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Simpson Manufacturing Company Inc.

SSD

Simpson Manufacturing Company Inc.

N/A

Current Price

$195.25

Market Cap

8.2B

ML Signal

N/A

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

N/A

Current Price

$101.88

Market Cap

8.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SSD
SYRE
Founded
1956
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
8.5B
IPO Year
1996
2015

Fundamental Metrics

Financial Performance
Metric
SSD
SYRE
Price
$195.25
$101.88
Analyst Decision
Buy
Strong Buy
Analyst Count
4
12
Target Price
$214.75
$85.08
AVG Volume (30 Days)
241.3K
861.0K
Earning Date
04-27-2026
05-08-2026
Dividend Yield
0.61%
N/A
EPS Growth
8.42
N/A
EPS
5.22
N/A
Revenue
$2,332,808,000.00
N/A
Revenue This Year
$3.82
N/A
Revenue Next Year
$5.57
N/A
P/E Ratio
$37.32
N/A
Revenue Growth
4.51
N/A
52 Week Low
$156.32
$14.51
52 Week High
$213.49
$108.14

Technical Indicators

Market Signals
Indicator
SSD
SYRE
Relative Strength Index (RSI) 52.17 53.94
Support Level $183.25 $92.37
Resistance Level $195.67 $105.09
Average True Range (ATR) 5.54 5.70
MACD 0.58 -0.40
Stochastic Oscillator 45.75 59.70

Price Performance

Historical Comparison
SSD
SYRE

About SSD Simpson Manufacturing Company Inc.

Simpson Manufacturing Co Inc designs, manufactures, and markets systems and products to make buildings and structures safe and secure. It produces wood construction products, including connectors, truss plates, fastening systems, fasteners, and shearwalls, as well as concrete construction products such as adhesives, specialty chemicals, mechanical anchors, powder actuated tools, and fiber reinforcing materials. The company serves residential, industrial, commercial, and infrastructure construction, remodeling, and do-it-yourself markets, operating exclusively in the building products industry. It has three regional segments: North America, Europe, and Asia/Pacific. The majority of its revenue comes from wood products.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23 in development as monotherapies and pair-wise combinations. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: